ENTA
Enanta Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
USD14.51
+0.51 (+3.64%)
Rating:C-
Company Profile
CEO
Jay R. Luly
IPO Date
2013-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$14.14
Prev. Close
$14.00
Day Low
$13.97
Day High
$14.73
52W Low
$6.43
52W High
$17.15
Market Cap
$0.34B
Volume
0.33M